跳至主要内容
临床试验/ACTRN12614000449639
ACTRN12614000449639招募中未知

The significance of hyperglycaemia in survivors of critical illness and potential mechanisms underlying development of type 2 diabetes

Dr Adam Deane0 个研究点目标入组 600 人开始时间: 2014年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 70 Years(—)
性别
All

入选标准

  • Critical Illness-associated hyperglycaemia: HbA1c < 6.5%, blood glucose concentrations > 11.1 mmol/l for at least two consecutive readings during ICU admission
  • Normoglycaemic: HbA1c < 6.5%, fasted blood glucose concentrations remain < 7.1mmol/l and random concentrations remain < 11.1 mmol/l throughout ICU admission
  • Healthy volunteers: >18 years of age, sex and BMI will be used to match volunteers

排除标准

  • Inability to give informed consent, current pregnancy, previous gestational diabetes, acute or chronic pancreatitis, medications known to affect glucose metabolism (e.g. steroids)

研究者

发起方
Dr Adam Deane

相似试验